Cargando…

Comparative assessment of commercial enzyme-linked immunosorbent assay & rapid diagnostic tests used for dengue diagnosis in India

BACKGROUND & OBJECTIVES: Dengue diagnosis is routinely carried out by detection of dengue virus (DENV) antigen NS1 and/or anti-DENV IgM antibodies using enzyme-linked immunosorbent assays (ELISAs) and rapid diagnostic tests (RDTs). This study was aimed at evaluation of quality of diagnostic assa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kulkarni, Ruta, Modak, Meera, Gosavi, Mrunal, Wani, Dileep, Mishra, Akhilesh C., Arankalle, Vidya A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055168/
https://www.ncbi.nlm.nih.gov/pubmed/32134017
http://dx.doi.org/10.4103/ijmr.IJMR_613_18
_version_ 1783503318515974144
author Kulkarni, Ruta
Modak, Meera
Gosavi, Mrunal
Wani, Dileep
Mishra, Akhilesh C.
Arankalle, Vidya A.
author_facet Kulkarni, Ruta
Modak, Meera
Gosavi, Mrunal
Wani, Dileep
Mishra, Akhilesh C.
Arankalle, Vidya A.
author_sort Kulkarni, Ruta
collection PubMed
description BACKGROUND & OBJECTIVES: Dengue diagnosis is routinely carried out by detection of dengue virus (DENV) antigen NS1 and/or anti-DENV IgM antibodies using enzyme-linked immunosorbent assays (ELISAs) and rapid diagnostic tests (RDTs). This study was aimed at evaluation of quality of diagnostic assays currently in use in India for the identification of DENV infection. METHODS: During 2016 dengue season (July-November) in Pune, India, comparative assessment of a few immunoassays was undertaken using (i) WHO-approved Panbio-Dengue-Early-(NS1)-ELISA and Panbio-Dengue-IgM-Capture-ELISA as reference tests, and (ii) Bayesian latent class analysis (BLCA) which assumes that no test is perfect. The assays included J.Mitra-Dengue-NS1-Ag-MICROLISA (JME-NS1), J.Mitra-Dengue-IgM-MICROLISA (JME-IgM), and two RDTs, namely, J.Mitra-Dengue-Day- 1-Test (JM-RDT) and SD-BIOLINE-Dengue-Duo (SDB-RDT). Serum samples from patients seeking dengue diagnosis (n=809) were tested using the diagnostic kits. The presence of NS1 and/or IgM was taken as evidence for dengue-positive diagnosis. RESULTS: Panbio-NS1/IgM-ELISAs identified 38.6 per cent patients as dengue positive. With Panbio-ELISA as reference, all the tests were less sensitive for IgM detection, while for NS1, JM-RDT was less sensitive. For combined diagnosis (both markers), sensitivity of all the tests was low (55.7-76.6%). According to BLCA, Panbio-ELISA was 84 per cent sensitive for NS1, 86 per cent specific for IgM and 87 per cent specific for combined diagnosis. Accordingly, performance of the other tests was substantially improved with BLCA; however, sensitivity of both the RDTs for IgM detection remained unacceptable. The NS1 ELISAs and RDTs detected all four DENV serotypes, JME being most efficient. All IgM tests exhibited higher sensitivity in secondary infections. INTERPRETATION & CONCLUSIONS: These results confirmed superiority of ELISAs, and testing for both NS1 and IgM markers for dengue diagnosis, and emphasized on improvement in sensitivity of RDTs.
format Online
Article
Text
id pubmed-7055168
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-70551682020-03-19 Comparative assessment of commercial enzyme-linked immunosorbent assay & rapid diagnostic tests used for dengue diagnosis in India Kulkarni, Ruta Modak, Meera Gosavi, Mrunal Wani, Dileep Mishra, Akhilesh C. Arankalle, Vidya A. Indian J Med Res Original Article BACKGROUND & OBJECTIVES: Dengue diagnosis is routinely carried out by detection of dengue virus (DENV) antigen NS1 and/or anti-DENV IgM antibodies using enzyme-linked immunosorbent assays (ELISAs) and rapid diagnostic tests (RDTs). This study was aimed at evaluation of quality of diagnostic assays currently in use in India for the identification of DENV infection. METHODS: During 2016 dengue season (July-November) in Pune, India, comparative assessment of a few immunoassays was undertaken using (i) WHO-approved Panbio-Dengue-Early-(NS1)-ELISA and Panbio-Dengue-IgM-Capture-ELISA as reference tests, and (ii) Bayesian latent class analysis (BLCA) which assumes that no test is perfect. The assays included J.Mitra-Dengue-NS1-Ag-MICROLISA (JME-NS1), J.Mitra-Dengue-IgM-MICROLISA (JME-IgM), and two RDTs, namely, J.Mitra-Dengue-Day- 1-Test (JM-RDT) and SD-BIOLINE-Dengue-Duo (SDB-RDT). Serum samples from patients seeking dengue diagnosis (n=809) were tested using the diagnostic kits. The presence of NS1 and/or IgM was taken as evidence for dengue-positive diagnosis. RESULTS: Panbio-NS1/IgM-ELISAs identified 38.6 per cent patients as dengue positive. With Panbio-ELISA as reference, all the tests were less sensitive for IgM detection, while for NS1, JM-RDT was less sensitive. For combined diagnosis (both markers), sensitivity of all the tests was low (55.7-76.6%). According to BLCA, Panbio-ELISA was 84 per cent sensitive for NS1, 86 per cent specific for IgM and 87 per cent specific for combined diagnosis. Accordingly, performance of the other tests was substantially improved with BLCA; however, sensitivity of both the RDTs for IgM detection remained unacceptable. The NS1 ELISAs and RDTs detected all four DENV serotypes, JME being most efficient. All IgM tests exhibited higher sensitivity in secondary infections. INTERPRETATION & CONCLUSIONS: These results confirmed superiority of ELISAs, and testing for both NS1 and IgM markers for dengue diagnosis, and emphasized on improvement in sensitivity of RDTs. Wolters Kluwer - Medknow 2020-01 /pmc/articles/PMC7055168/ /pubmed/32134017 http://dx.doi.org/10.4103/ijmr.IJMR_613_18 Text en Copyright: © 2020 Indian Journal of Medical Research http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Kulkarni, Ruta
Modak, Meera
Gosavi, Mrunal
Wani, Dileep
Mishra, Akhilesh C.
Arankalle, Vidya A.
Comparative assessment of commercial enzyme-linked immunosorbent assay & rapid diagnostic tests used for dengue diagnosis in India
title Comparative assessment of commercial enzyme-linked immunosorbent assay & rapid diagnostic tests used for dengue diagnosis in India
title_full Comparative assessment of commercial enzyme-linked immunosorbent assay & rapid diagnostic tests used for dengue diagnosis in India
title_fullStr Comparative assessment of commercial enzyme-linked immunosorbent assay & rapid diagnostic tests used for dengue diagnosis in India
title_full_unstemmed Comparative assessment of commercial enzyme-linked immunosorbent assay & rapid diagnostic tests used for dengue diagnosis in India
title_short Comparative assessment of commercial enzyme-linked immunosorbent assay & rapid diagnostic tests used for dengue diagnosis in India
title_sort comparative assessment of commercial enzyme-linked immunosorbent assay & rapid diagnostic tests used for dengue diagnosis in india
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7055168/
https://www.ncbi.nlm.nih.gov/pubmed/32134017
http://dx.doi.org/10.4103/ijmr.IJMR_613_18
work_keys_str_mv AT kulkarniruta comparativeassessmentofcommercialenzymelinkedimmunosorbentassayrapiddiagnostictestsusedfordenguediagnosisinindia
AT modakmeera comparativeassessmentofcommercialenzymelinkedimmunosorbentassayrapiddiagnostictestsusedfordenguediagnosisinindia
AT gosavimrunal comparativeassessmentofcommercialenzymelinkedimmunosorbentassayrapiddiagnostictestsusedfordenguediagnosisinindia
AT wanidileep comparativeassessmentofcommercialenzymelinkedimmunosorbentassayrapiddiagnostictestsusedfordenguediagnosisinindia
AT mishraakhileshc comparativeassessmentofcommercialenzymelinkedimmunosorbentassayrapiddiagnostictestsusedfordenguediagnosisinindia
AT arankallevidyaa comparativeassessmentofcommercialenzymelinkedimmunosorbentassayrapiddiagnostictestsusedfordenguediagnosisinindia